Next Article in Journal / Special Issue
New Strategies for the Treatment of Phenylketonuria (PKU)
Previous Article in Journal
An Efficient High Throughput Metabotyping Platform for Screening of Biomass Willows
Previous Article in Special Issue
Establishment of Glycosaminoglycan Assays for Mucopolysaccharidoses
Article Menu

Export Article

Open AccessReview
Metabolites 2014, 4(4), 977-1006; doi:10.3390/metabo4040977

Clinically Important Features of Porphyrin and Heme Metabolism and the Porphyrias

Department of Medicine and Center for Liver Disease, Carolinas HealthCare System, Charlotte, NC 28204, USA
Department of Research and the Liver, Digestive, and Metabolic Disorders Laboratory, Carolinas HealthCare System, Charlotte, NC 28203, USA
Department of Medicine, Universities of CT, Farmington, CT 06030 and North Carolina, Chapel Hill, NC 27599, USA
Author to whom correspondence should be addressed.
Received: 31 May 2014 / Revised: 14 October 2014 / Accepted: 16 October 2014 / Published: 3 November 2014
(This article belongs to the Special Issue Inborn Errors of Metabolism)
View Full-Text   |   Download PDF [337 KB, uploaded 3 November 2014]   |  


Heme, like chlorophyll, is a primordial molecule and is one of the fundamental pigments of life. Disorders of normal heme synthesis may cause human diseases, including certain anemias (X-linked sideroblastic anemias) and porphyrias. Porphyrias are classified as hepatic and erythropoietic porphyrias based on the organ system in which heme precursors (5-aminolevulinic acid (ALA), porphobilinogen and porphyrins) are chiefly overproduced. The hepatic porphyrias are further subdivided into acute porphyrias and chronic hepatic porphyrias. The acute porphyrias include acute intermittent, hereditary copro-, variegate and ALA dehydratase deficiency porphyria. Chronic hepatic porphyrias include porphyria cutanea tarda and hepatoerythropoietic porphyria. The erythropoietic porphyrias include congenital erythropoietic porphyria (Gűnther’s disease) and erythropoietic protoporphyria. In this review, we summarize the key features of normal heme synthesis and its differing regulation in liver versus bone marrow. In both organs, principal regulation is exerted at the level of the first and rate-controlling enzyme, but by different molecules (heme in the liver and iron in the bone marrow). We also describe salient clinical, laboratory and genetic features of the eight types of porphyria. View Full-Text
Keywords: 5-aminolevulinic acid; heme; iron; metalloporphyrins; mitochondria; porphobilinogen; porphyrias; porphyrins 5-aminolevulinic acid; heme; iron; metalloporphyrins; mitochondria; porphobilinogen; porphyrias; porphyrins

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Besur, S.; Hou, W.; Schmeltzer, P.; Bonkovsky, H.L. Clinically Important Features of Porphyrin and Heme Metabolism and the Porphyrias. Metabolites 2014, 4, 977-1006.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Metabolites EISSN 2218-1989 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top